Definitive Contract HHSN272201500028C

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, awarded a $10,650.00 firm fixed-price purchase order contract to Scale Biosciences, Inc. for the procurement of RNA kits. This contract has a total small business set-aside designation and a period of performance through December 31, 2024. As NIAID is responsible for conducting and supporting research to understand, treat, and prevent infectious diseases, this contract award is likely related to their...

This $299,040 firm-fixed-price Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The objective is to design and synthesize a new PLGA-based nanoparticle with an optimal protein-adjuvant formulation that combines targeting and controlled delivery for immunization...

The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $22,941 firm fixed price purchase order to Nanostring Technologies, Inc. of Seattle, Washington. The contract is for the delivery of RNA consumables to support assay activity. No additional details were provided regarding the specific assays or research being supported. The place of performance is Nanostring's headquarters in Seattle. The period of...

This is a $299,208 firm fixed price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to John Snow Labs Inc., a self-certified small disadvantaged business. The contract is for SBIR Topic 135, with a period of performance through September 4, 2025. The contract does not have a set-aside designation. As an SBIR (Small Business Innovation Research) contract, it is part of a larger SBIR program managed by NIAID to fund research and...

This $1,797,717.00 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH), to Intralytix Inc., a biotechnology company specializing in bacteriophage-based products. The contract is for the development of a "Universal, Scalable Artificial Intelligence-Based Platform for Manufacturing High Titer Biopharmaceuticals", which aligns with...

This is a task order award under a broader Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a ceiling value of $1,429,082.54. The prime contractor is Battelle Memorial Institute, a large non-profit research and development organization. The contracting agency is the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The task order is for $132,813 and has an ultimate completion date of April 17,...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Kitware Inc., a small business S corporation located in Clifton Park, New York. The contract has a ceiling value of $299,999 and is a definitive, firm-fixed-price contract with a completion date of September 5, 2025. The contract is not set aside for a specific business type. The contract involves research and development work,...

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $111,894.56 firm fixed price purchase order contract to Precision Nanosystems US Inc., a for-profit organization. The contract is for the provision of a NanoAssemblr Ignite Automated Microfluidics Instrument, with a performance period ending on October 30, 2022. Precision Nanosystems has previously provided similar microfluidics and nanoparticle...

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded a $33,273,522 cost-plus-fixed-fee definitive contract to Anivive Lifesciences Inc., a self-certified small disadvantaged business, to develop vaccine candidates for biodefense and emerging infectious diseases. This contract, awarded on June 7, 2024, is part of NIAID's Broad Agency Announcement (BAA) research program and has a completion date of June 1, 2026. The contract...

This is a $225,000.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Nanocomposix, Inc., a manufacturer of engineered nanoparticles. The contract is for the development of "TOPIC 59 DIAGNOSTICS TO ENABLE MALARIA AND NEGLECTED TROPICAL DISEASES". Nanocomposix has previously provided lateral flow assay devices, gold nanoparticles, and research and development...